Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Aldesleukin
(125-L-serine-2-133-interleukin 2)
[3] Aldesleukin; ILT-101; Recombinant human interleukin-2[1] Aldesleukin 💬 [3] IL2RA,
IL2RB,
IL2RG 💬
[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[6] 2, 35, 49, 65, 96, 97 💬
2 Cycloserine
(cyclo-D-Serine)
[1] Cycloserine[1] Cycloserine 💬 --[1] 2 💬
3 D-Serine
(D-Serine)
[1] D-serine---[1] 6 💬
4 OMS906
(Humanized immunoglobulin G4 monoclonal antibody directed against mannan-binding lectin-associated serine protease-3)
[0] ---[1] 62 💬
5 Serine
(Serine)
[1] Serine[1] Serine (Serine, L-Serine) 💬 --[1] 86 💬